Alachkar N, Ugarte R, Huang E, Womer K L, Montgomery R, Kraus E, Rabb H
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Transplant Proc. 2010 Nov;42(9):3399-405. doi: 10.1016/j.transproceed.2010.06.013.
Delayed graft function (DGF) and slow graft function (SGF) due to ischemic and reperfusion injury (IRI) are common complications of deceased donor kidney transplantation. We tested whether a panel of serum and urine cytokines represent early biomarkers for DGF and SGF.
We collected serum and urine samples from 61 patients 48 hours posttransplantation and used a multiplex enzyme-linked immunosorbent assay (ELISA) technique to measure levels of 23 cytokines. Fourteen patients developed poor graft function (PGF), with 6 having DGF and 8 with SGF.
Area under receiver operation characteristics curve (AUC) demonstrated the following: serum levels of SCF (0.88) and interleukin (IL) 16 (0.74).
This study showed that a select panel of cytokines measured early post kidney transplantation may predict poor graft function.
由于缺血再灌注损伤(IRI)导致的移植肾功能延迟恢复(DGF)和移植肾功能缓慢恢复(SGF)是尸体供肾移植常见的并发症。我们测试了一组血清和尿液细胞因子是否可作为DGF和SGF的早期生物标志物。
我们在移植后48小时收集了61例患者的血清和尿液样本,并使用多重酶联免疫吸附测定(ELISA)技术来测量23种细胞因子的水平。14例患者移植肾功能不佳(PGF),其中6例发生DGF,8例发生SGF。
受试者操作特征曲线下面积(AUC)显示如下:血清干细胞因子(SCF)水平为0.88,白细胞介素(IL)-16水平为0.74。
本研究表明,肾移植后早期检测的一组特定细胞因子可能预测移植肾功能不佳。